We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.85B
AUM Growth
-$949M
(-20%)
Cap. Flow
-$393M
Cap. Flow
% of AUM
-10.22%
Top 10 Holdings %
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$67.9M |
| 2 |
FSAC
Federal Street Acquisition Corp. Common Stock
FSAC
|
+$45.5M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$45.2M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$34.6M |
| 5 |
NFX
Newfield Exploration
NFX
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$105M |
| 2 |
COL
Rockwell Collins
COL
|
+$84.8M |
| 3 |
CA
CA, Inc.
CA
|
+$72.4M |
| 4 |
ANDV
Andeavor
ANDV
|
+$52.9M |
| 5 |
PF
Pinnacle Foods, Inc.
PF
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 14.53% |
| 3 | Healthcare | 13.43% |
| 4 | Industrials | 13.16% |
| 5 | Financials | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Corbus Pharmaceuticals
CRBP
$190M
| $339K | 0.01% |
+1,934
| New | +$386K |
|
|
APLS
1352
DELISTED
Apellis Pharmaceuticals
APLS
| $338K | 0.01% |
+25,610
| New | +$393K |
|
1353
Nicolet Bankshares
NIC
$3.62B
| $338K | 0.01% |
6,926
+295
| +4% | +$15.3K |
|
|
BERY
1354
DELISTED
Berry Global Group, Inc.
BERY
| $338K | 0.01% |
+7,742
| New | +$330K |
|
1355
Fortuna Silver Mines
FSM
$3.07B
| $337K | 0.01% |
92,608
+26,316
| +40% | +$97.1K |
|
1356
Stagwell
STGW
$2.24B
| $337K | 0.01% |
+129,043
| New | +$367K |
|
1357
Lindblad Expeditions
LIND
$2.22B
| $336K | 0.01% |
24,933
-7,710
| -24% | -$103K |
|
1358
First Financial Corp
THFF
$969M
| $336K | 0.01% |
+8,372
| New | +$385K |
|
1359
UFP Technologies
UFPT
$2.43B
| $336K | 0.01% |
11,190
-6,631
| -37% | -$227K |
|
|
VNET
1360
VNET Group
VNET
$2.09B
| $336K | 0.01% |
38,877
-5,229
| -12% | -$51.8K |
|
|
AHG
1361
Akso Health Group
AHG
$1.16B
| $332K | 0.01% |
+44,268
| New | +$729K |
|
1362
OptimizeRx
OPRX
$133M
| $332K | 0.01% |
+30,231
| New | +$447K |
|
1363
Parker-Hannifin
PH
$135B
| $332K | 0.01% |
2,226
-4,607
| -67% | -$746K |
|
1364
1st Source
SRCE
$2.12B
| $332K | 0.01% |
+8,219
| New | +$383K |
|
1365
Bank of Marin Bancorp
BMRC
$459M
| $330K | 0.01% |
7,990
-2,750
| -26% | -$112K |
|
|
NMTR
1366
DELISTED
9 Meters Biopharma
NMTR
| $330K | 0.01% |
+7,144
| New | +$529K |
|
|
FSCT
1367
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $328K | 0.01% |
+12,605
| New | +$349K |
|
1368
Build-A-Bear
BBW
$462M
| $327K | 0.01% |
82,879
-38,459
| -32% | -$271K |
|
|
ADVM
1369
DELISTED
Adverum Biotechnologies
ADVM
| $326K | 0.01% |
10,336
+2,611
| +34% | +$106K |
|
|
CTO
1370
CTO Realty Growth
CTO
$815M
| $326K | 0.01% |
22,844
-4,760
| -17% | -$74.5K |
|
1371
Kingstone Companies
KINS
$276M
| $325K | 0.01% |
18,346
-17,884
| -49% | -$299K |
|
|
SJR
1372
DELISTED
Shaw Communications Inc.
SJR
| $325K | 0.01% |
17,959
-50,845
| -74% | -$954K |
|
1373
Sierra Bancorp
BSRR
$525M
| $320K | 0.01% |
13,337
+3,105
| +30% | +$83.4K |
|
1374
Preferred Bank
PFBC
$1.25B
| $320K | 0.01% |
7,374
+716
| +11% | +$36.6K |
|
|
FSP
1375
Franklin Street Properties
FSP
$46.8M
| $319K | 0.01% |
+51,234
| New | +$376K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.
- Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
- Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
- Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
- Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
- Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
- Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
- Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.
Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.